However, it is not known if reduced serum triglycerides lead to improved glycemic control as Whole Body Insulin Sensitivity Index did not significantly increase with either dose compared to placebo and no participants with T2DM were enrolled in this trial (40). The gene discussed is INS; the disease is type 2 diabetes mellitus.